| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |